Direktorat Registrasi ObatValid

LEVOFLOXACIN HEMIHYDRATE

BPOM Number: GKL2140814817A1
Approved: 21 November 2024
Expiry: 1 June 2026
Form: TABLET SALUT SELAPUT; 512,5 MG

About This Registration

LEVOFLOXACIN HEMIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2140814817A1. Its current registration status is Valid, with the licence valid until 1 June 2026. The product is registered to INFION - INDONESIA. BPOM first approved this registration in June 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 10 BLISTER @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INFION - INDONESIA
KAB. PASURUAN
NPWP: 025131913624000
owner
View profile →

Manufacturing Sites

INFION - INDONESIA
KAB. PASURUAN
primary
View profile →

Ingredients (1)

LEVOFLOXACIN HEMIHYDRATE

Market Intelligence

Owner Portfolio: INFION - INDONESIA holds 162 BPOM registrations
Manufacturer Scale: INFION - INDONESIA produces 162 registered products
Registration Age: Registered for 5 years, 3 months
Expiry Status: Expired 118 days ago

FDA Cross-Reference

via openFDA

Generic Name: LEVOFLOXACIN
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?